Trace analysis of solid forms by Synchrotron X-Ray Powder Diffraction (S-XRPD) overcomes the limits of standard laboratory XRPD.
Thanks to Excelsus Structural Solutions (ESS), such unique analysis has become easily achievable for us, and we have already made use of it at different stages of our projects with excellent support from ESS.
S-XRPD is becoming an inherent part of the characterization of pharmaceutics also for generic companies.
At Zentiva, the development of innovative drug products drives us towards the continuous search for new challenges in pharmaceutical technologies as well as advanced analytical techniques and fruitful collaboration. Ours with ESS certainly belongs to such a category.
Ondrej Dammer, PhD
Praha – Czech republic